Sonnet BioTherapeutics
Why Robinhood?
You can watch SONN and buy or sell other stocks, ETFs, and their options commission-free!About SONN
Sonnet BioTherapeutics Holdings, Inc. is a clinical stage biotechnology company, which engages in the innovation of biologic medicines. Its Fully Human Albumin Binding (FHAB) technology utilizes a single chain antibody fragment that binds to and hitch-hikes on human serum albumin for transport to target tissues.
SONN Key Statistics
Stock Snapshot
The current Sonnet BioTherapeutics(SONN) stock price is $1.26, with a market capitalization of 6.56M. The stock trades at a price-to-earnings (P/E) ratio of -1.88.
During the trading day, Sonnet BioTherapeutics(SONN) stock saw an opening price of —, a peak of —, and a bottom of —.
Trading volume for Sonnet BioTherapeutics(SONN) stock has reached 0, versus its average volume of 104.32K.
The stock's 52-week range extends from a low of $0.62 to a high of $2.97.
The stock's 52-week range extends from a low of $0.62 to a high of $2.97.
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.